跳至主要内容
临床试验/DRKS00033584
DRKS00033584招募中不适用

A prospective, global study designed to collect real-world clinical outcomes of the MITRIS RESILIA mitral valve - Europe (MOMENTIS) - MOMENTIS

Edwards Lifesciences LLC0 个研究点目标入组 120 人开始时间: 2024年5月10日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • 1. 18 years or older at the time of informed consent
  • 2. Has a dysfunctional native or prosthetic mitral valve and requires mitral valve replacement surgery
  • 3. Provides written informed consent
  • 4. Willingness to follow protocol requirements

排除标准

  • 1. Active endocarditis 3 months prior to the procedure
  • 2. Stage 4 renal disease or requiring dialysis*
  • 3. Less than 2-year life expectancy due to non-cardiovascular life-threatening disease
  • 4. High predicted risk of mortality prior to procedure
  • STS PROM > 8 or
  • Surgeon estimated risk of mortality of > 8
  • *eGFR < 30 is excluded

研究者

相似试验